| 
					
						|  |  
    					|  |  
    					| The potential molecular mechanism of overexpression of uPA, IL-8, MMP-7 and MMP-9 induced by TRAIL in pancreatic cancer cell |  
						| Dong-Hui Zhou, Anna Trauzold, Christian Röder, Gang Pan, Cheng Zheng and Holger Kalthoff |  
						| Hangzhou, China 
 Author Affiliations: Department of Oncology, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China (Zhou DH, Pan G and Zheng C); and Molecular Oncology Research Laboratory, Clinic for General and Thoracic Surgery, Christian-Albrechts-University, 24105 Kiel, Germany (Trauzold A, Röder C and Kalthoff H)
 Corresponding Author: Dong-Hui Zhou, MD, Department of Oncology, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China (Tel: 86-571-87236878; Fax: 86-571-86027898; Email: zdh19838@hotmail.com)
 |  
						|  |  
					
						| 
								
									| 
											
                        					 
												
													
													    |  |  
														| 
													
													    | Abstract BACKGROUND: TNF-related apoptosis-inducing ligand (TRAIL) is a death ligand of the TNF-superfamily that has been implicated in inducing apoptosis in some tumor cells. The purpose of this study was to find out if TRAIL could induce the expression of uPA, IL-8, MMP-7 and MMP-9.and to explore the corresponding potential signaling transduction pathway in pancreatic cancer cells. 
METHODS: Colo357wt, Panc89 and PancTuⅠ cell lines were stimulated by TRAIL (100 ng/ml). Crystal violet cell vitality assay was used to check the sensitivity to TRAIL-induced apoptosis. Real-time RT-PCR tested the expression of uPA, IL-8, MMP-7 and MMP-9. 
RESULTS: TRAIL can stimulate the expression of uPA, IL-8, MMP-7 and MMP-9 in pancreatic cancer cell lines, especially in Colo357wt. The members of caspases, MEK1/2, PKC, and NF-κB are involved in TRAIL-induced expression of uPA, IL-8, MMP-7 and MMP-9. Furthermore, caspases play a different role in Colo357wt, Panc89 and PancTuⅠ.
CONCLUSIONS: TRAIL-treatment may result in the enhancement of invasion involving the signaling pathways of caspases, MEK1/2, PKC and NF-κB, in pancreatic cancer cells. It points to the necessity to carefully evaluate in vivo side effects of TRAIL. |  
															|  |  |  |  |  
														
															| Cite this article: |  
															| Zhou DH,
																																																																																																Trauzold A,
																																																																																																																R?der C,
																et al.
																																																																																																																																																																																																																																																																																																																 The potential molecular mechanism of overexpression of uPA, IL-8, MMP-7 and MMP-9 induced by TRAIL in pancreatic cancer cell. 
																Hepatobiliary Pancreat Dis Int 
																2008;
																7(2): 
																201-209. DOI: |  |  |  
															|  |  |  |  
															| URL: |  
															| http://dx.doi.org/     OR     http://www.hbpdint.com/EN/Y2008/V7/I2/201 |  
											 
											 |  |  |